Multifocal motor neuropathy: Association of anti-GM1 IgM antibodies with clinical features

Neurology

Volumn 75, Issue 22, 2010, Pages 1961-1967

  Cats, E A ^a   Jacobs, B C ^c   Yuki, N ^d   Tio Gillen, A P ^c   Piepers, S ^a   Franssen, H ^b   Van Asseldonk, J T ^a   Van Den Berg, L H ^a   Van Der Pol, W L ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLIOSIDE; GANGLIOSIDE GD 1A; GANGLIOSIDE GD 1B; GANGLIOSIDE GD2; GANGLIOSIDE GM1; GANGLIOSIDE GQ 1B; GANGLIOSIDE GT 1B; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ADULT; AGED; ANTIBODY TITER; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CROSS REACTION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR NEUROPATHY; PRIORITY JOURNAL; VIBRATION SENSE;

ADULT; AGED; ANTIBODIES, ANTI-IDIOTYPIC; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; ELECTRODIAGNOSIS; FEMALE; GANGLIOSIDES; HUMANS; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; MOTOR NEURONS; NEURAL CONDUCTION; POLYNEUROPATHIES; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 78650029703     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181ff94c2     Document Type: Article

References (37)

1. Parry GJ, Clarke S. Multifocal acquired demyelinating neuropathy masquerading as motor neuron disease. Muscle Nerve 1988;11:103-107.
2. Pestronk A, Cornblath DR, Ilyas AA, et al. A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside. Ann Neurol 1988;24:73-78.
3. Van Schaik I, Bossuyt PM, Brand A, Vermeulen M. Diagnostic value of GM1 antibodies in motor neuron disorders and neuropathies: A meta-analysis. Neurology 1995;45: 1570-1577.
4. Taylor BV, Gross L, Windebank AJ. The sensitivity and specificity of anti-GM1 antibody testing. Neurology 1996; 47:951-955.
5. Willison HJ, Veitch J, Swan AV, et al. Inter-laboratory validation of an ELISA for the determination of serum anti-ganglioside antibodies. Eur J Neurol 1999;6:71-77.
6. Willison HJ, Yuki N. Peripheral neuropathies and antiglycolipid antibodies. Brain 2002;125:2591-2625.
7. Nobile-Orazio E, Gallia F, Terenghi F, Allaria S, Giannotta C, Carpo M. How useful are anti-neural IgM antibodies in the diagnosis of chronic immune-mediated neuropathies? J Neurol Sci 2008;266:156-163.
8. Yuki N, Yoshino H, Sato S, Miyatake T. Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis. Neurology 1990;40: 1900-1902.
9. Rees JH, Gregson NA, Hughes RA. Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection. Ann Neurol 1995;38:809-816.
10. Ho TW, Willison HJ, Nachamkin I, et al. Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome. Ann Neurol 1999;45: 168-173.
11. Yuki N, Ho TW, Tagawa Y, et al. Autoantibodies to GM1b and GalNAc-GD1a: Relationship to Campylobacter jejuni infection and acute motor axonal neuropathy in China. J Neurol Sci 1999;164:134-138.
12. Hao Q, Saida T, Yoshino H, Kuroki S, Nukina M, Saida K. Anti-GalNAc-GD1a antibody-associated Guillain- Barré syndrome with a predominantly distal weakness without cranial nerve impairment and sensory disturbance. Ann Neurol 1999;45:758-768.
13. Ogawara K, Kuwabara S, Mori M, Hattori T, Koga M, Yuki N. Axonal Guillain-Barre syndrome: Relation to antiganglioside antibodies and Campylobacter jejuni infection in Japan. Ann Neurol 2000;48:624-631.
14. O'Leary CP, Willison HJ. Autoimmune ataxic neuropathies (sensory ganglionopathies). Curr Opin Neurol 1997; 10:366-370.
15. Kaida K, Kamakura K, Ogawa G, et al. GD1b-specific antibody induces ataxia in Guillain-Barré syndrome. Neurology 2008;71:196-201.
16. Kaida K, Morita D, Kanzaki M, et al. Ganglioside complexes as new target antigens in Guillain-Barré syndrome. Ann Neurol 2004;56:567-571.
17. Kaida K, Sonoo M, Ogawa G, et al. GM1/GalNAc-GD1a complex: A target for pure motor Guillain-Barré syndrome. Neurology 2008;71:1683-1690.
18. Cats EA, Van der Pol WL, Piepers S, et al. Correlates of outcome and response to IVIg in 88 patients with multifocal motor neuropathy. Neurology 2010;75:818-825.
19. Van den Berg-Vos R, Franssen H, Wokke JH, Van Es HW, Van den Berg LH. Multifocal motor neuropathy: Diagnostic criteria that predict the response to immunoglobulin treatment. Ann Neurol 2000;48:919-926.
20. Van Es HW, Van den Berg LH, Franssen H, et al. Magnetic resonance imaging of the brachial plexus in patients with multifocal motor neuropathy. Neurology 1997;48: 1218-1224.
21. Merkies IS, Schmitz PI, van der Meche FG, van Doorn PA. Reliability and responsiveness of a graduated tuning fork in immune mediated polyneuropathies: The Inflammatory Neuropathy Cause and Treatment (INCAT) Group. J Neurol Neurosurg Psychiatry 2000;68:669-671.
22. Merkies IS, Schmitz PI. Getting closer to patients: The INCAT Overall Disability Sum Score relates better to patients' own clinical judgment in immune-mediated polyneuropathies. J Neurol Neurosurg Psychiatry 2006; 77:970-972.
23. Van Asseldonk JT, Van den Berg LH, Van den Berg-Vos RM, Wieneke GH, Wokke JH, Franssen H. Demyelination and axonal loss in multifocal motor neuropathy: Distribution and relation to weakness. Brain 2003;126: 186-198.
24. Kuijf ML, van Doorn PA, Tio-Gillen AP, et al. Diagnostic value of anti-GM1 ganglioside serology and validation of the INCAT-ELISA. J Neurol Sci 2005;239:37-44.
25. Susuki K, Yuki N, Hirata K. Features of sensory ataxic neuropathy associated with anti-GD1b IgM antibody. J Neuroimmunol 2001;112:181-187.
26. Koga M, Tatsumoto M, Yuki N, Hirata K. Range of cross reactivity of anti-GM1 IgG antibody in Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry 2001;71:123-124.
27. Rinaldi S, Brennan KM, Goodyear CS, et al. Analysis of lectin binding to glycolipid complexes using combinatorial glycoarrays. Glycobiology 2009;19:789-796.
28. Nobile-Orazio E. Multifocal motor neuropathy. J Neuroimmunol 2001;115:4-18.
29. Slee M, Selvan A, Donaghy M. Multifocal motor neuropathy: The diagnostic spectrum and response to treatment. Neurology 2007;69:1680-1687.
30. Taylor BV, Wright RA, Harper CM, Dyck PJ. Natural history of 46 patients with multifocal motor neuropathy with conduction block. Muscle Nerve 2000;23:900-908.
31. Uetz-von Allmen E, Sturzenegger M, Rieben R, Rihs F, Frauenfelder A, Nydegger UE. Antiganglioside GM1 antibodies and their complement activating capacity in central and peripheral nervous system disorders and in controls. Eur Neurol 1998;39:103-110.
32. Susuki K, Rasband MN, Tohyama K, et al. Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers. J Neurosci 2007;27:3956-3967.
33. Lewis RA. Neuropathies associated with conduction block. Curr Opin Neurol 2007;20:525-530.
34. Tatsumoto M, Koga M, Gilbert M, et al. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a. J Neuroimmunol 2006;177:201-208.
35. Van Doorn PA, Ruts L, Jacobs BC. Clinical features, pathogenesis, and treatment of Guillain-Barre syndrome. Lancet Neurol 2008;7:939-950.
36. Kaida K, Morita D, Kanzaki M, et al. Anti-ganglioside complex antibodies associated with severe disability in GBS. J Neuroimmunol 2007;182:212-218.
37. Nobile-Orazio E, Giannotta C, Briani C. Anti-ganglioside complex IgM antibodies in multifocal motor neuropathy and chronic immune-mediated neuropathies. J Neuroimmunol 2010;26:119-122.